Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma

Toru Onishi, Kazuhiro Nouso, Toshihiro Higashi, Nobuyuki Toshikuni, Harushige Nakatsukasa, Yoshiyuki Kobayashi, Masayuki Uemura, Eiichiro Yumoto, Keishi Fujiwara, Shuichiro Sato, Shinichiro Nakamura, Junko Yokoyama, Tadashi Hanafusa, Yasushi Shiratori

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background and Aim: Telomerase is the enzyme that synthesizes telomeric DNA, and the activation of telomerase is closely related to cellular immortality. Telomerase activity has been reported in many human cancer tissues and is regulated by the expression of human telomerase reverse transcriptase (hTERT). The aim of the present study was to identify hTERT-expressing cells in human liver tissues and evaluate the feasibility of the hTERT promoter for gene therapy of hepatocellular carcinoma (HCC). Methods: The authors examined the cellular distribution of hTERT transcripts in surgically resected HCC by in situ hybridization. Results: Among 20 samples, hTERT expression was observed in 15 HCC. Transcripts of hTERT were homogenously distributed in the cytoplasm of HCC cells in nine of 15 cases; six of 15 cases displayed a heterogeneous staining pattern. All poorly differentiated HCC that expressed hTERT showed a homogenous pattern of staining. None of the non-cancerous hepatocytes were positive for the transcripts, but infiltrating lymphocytes were faintly stained. The homogenous expression of hTERT was also observed in the vascular invasion of HCC. Conclusions: The results indicate that most HCC cells express hTERT RNA and that the promoter is a good candidate as a target for gene therapy. However, careful consideration must be taken concerning the potential effects on lymphocytes.

Original languageEnglish
Pages (from-to)1168-1174
Number of pages7
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume18
Issue number10
DOIs
Publication statusPublished - 2003

Fingerprint

Hepatocellular Carcinoma
Telomerase
Genetic Therapy
Lymphocytes
Staining and Labeling
human TERT protein
Carcinoma in Situ
In Situ Hybridization
Blood Vessels
Hepatocytes
Cytoplasm
RNA
Liver
DNA
Enzymes
Neoplasms

Keywords

  • Gene therapy
  • In situ hybridization
  • Liver

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Onishi, T., Nouso, K., Higashi, T., Toshikuni, N., Nakatsukasa, H., Kobayashi, Y., ... Shiratori, Y. (2003). Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma. Journal of Gastroenterology and Hepatology (Australia), 18(10), 1168-1174. https://doi.org/10.1046/j.1440-1746.2003.03137.x

Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma. / Onishi, Toru; Nouso, Kazuhiro; Higashi, Toshihiro; Toshikuni, Nobuyuki; Nakatsukasa, Harushige; Kobayashi, Yoshiyuki; Uemura, Masayuki; Yumoto, Eiichiro; Fujiwara, Keishi; Sato, Shuichiro; Nakamura, Shinichiro; Yokoyama, Junko; Hanafusa, Tadashi; Shiratori, Yasushi.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 18, No. 10, 2003, p. 1168-1174.

Research output: Contribution to journalArticle

Onishi, T, Nouso, K, Higashi, T, Toshikuni, N, Nakatsukasa, H, Kobayashi, Y, Uemura, M, Yumoto, E, Fujiwara, K, Sato, S, Nakamura, S, Yokoyama, J, Hanafusa, T & Shiratori, Y 2003, 'Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma', Journal of Gastroenterology and Hepatology (Australia), vol. 18, no. 10, pp. 1168-1174. https://doi.org/10.1046/j.1440-1746.2003.03137.x
Onishi, Toru ; Nouso, Kazuhiro ; Higashi, Toshihiro ; Toshikuni, Nobuyuki ; Nakatsukasa, Harushige ; Kobayashi, Yoshiyuki ; Uemura, Masayuki ; Yumoto, Eiichiro ; Fujiwara, Keishi ; Sato, Shuichiro ; Nakamura, Shinichiro ; Yokoyama, Junko ; Hanafusa, Tadashi ; Shiratori, Yasushi. / Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma. In: Journal of Gastroenterology and Hepatology (Australia). 2003 ; Vol. 18, No. 10. pp. 1168-1174.
@article{22fb207f170e46fbaf20ed6ad72864e5,
title = "Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma",
abstract = "Background and Aim: Telomerase is the enzyme that synthesizes telomeric DNA, and the activation of telomerase is closely related to cellular immortality. Telomerase activity has been reported in many human cancer tissues and is regulated by the expression of human telomerase reverse transcriptase (hTERT). The aim of the present study was to identify hTERT-expressing cells in human liver tissues and evaluate the feasibility of the hTERT promoter for gene therapy of hepatocellular carcinoma (HCC). Methods: The authors examined the cellular distribution of hTERT transcripts in surgically resected HCC by in situ hybridization. Results: Among 20 samples, hTERT expression was observed in 15 HCC. Transcripts of hTERT were homogenously distributed in the cytoplasm of HCC cells in nine of 15 cases; six of 15 cases displayed a heterogeneous staining pattern. All poorly differentiated HCC that expressed hTERT showed a homogenous pattern of staining. None of the non-cancerous hepatocytes were positive for the transcripts, but infiltrating lymphocytes were faintly stained. The homogenous expression of hTERT was also observed in the vascular invasion of HCC. Conclusions: The results indicate that most HCC cells express hTERT RNA and that the promoter is a good candidate as a target for gene therapy. However, careful consideration must be taken concerning the potential effects on lymphocytes.",
keywords = "Gene therapy, In situ hybridization, Liver",
author = "Toru Onishi and Kazuhiro Nouso and Toshihiro Higashi and Nobuyuki Toshikuni and Harushige Nakatsukasa and Yoshiyuki Kobayashi and Masayuki Uemura and Eiichiro Yumoto and Keishi Fujiwara and Shuichiro Sato and Shinichiro Nakamura and Junko Yokoyama and Tadashi Hanafusa and Yasushi Shiratori",
year = "2003",
doi = "10.1046/j.1440-1746.2003.03137.x",
language = "English",
volume = "18",
pages = "1168--1174",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma

AU - Onishi, Toru

AU - Nouso, Kazuhiro

AU - Higashi, Toshihiro

AU - Toshikuni, Nobuyuki

AU - Nakatsukasa, Harushige

AU - Kobayashi, Yoshiyuki

AU - Uemura, Masayuki

AU - Yumoto, Eiichiro

AU - Fujiwara, Keishi

AU - Sato, Shuichiro

AU - Nakamura, Shinichiro

AU - Yokoyama, Junko

AU - Hanafusa, Tadashi

AU - Shiratori, Yasushi

PY - 2003

Y1 - 2003

N2 - Background and Aim: Telomerase is the enzyme that synthesizes telomeric DNA, and the activation of telomerase is closely related to cellular immortality. Telomerase activity has been reported in many human cancer tissues and is regulated by the expression of human telomerase reverse transcriptase (hTERT). The aim of the present study was to identify hTERT-expressing cells in human liver tissues and evaluate the feasibility of the hTERT promoter for gene therapy of hepatocellular carcinoma (HCC). Methods: The authors examined the cellular distribution of hTERT transcripts in surgically resected HCC by in situ hybridization. Results: Among 20 samples, hTERT expression was observed in 15 HCC. Transcripts of hTERT were homogenously distributed in the cytoplasm of HCC cells in nine of 15 cases; six of 15 cases displayed a heterogeneous staining pattern. All poorly differentiated HCC that expressed hTERT showed a homogenous pattern of staining. None of the non-cancerous hepatocytes were positive for the transcripts, but infiltrating lymphocytes were faintly stained. The homogenous expression of hTERT was also observed in the vascular invasion of HCC. Conclusions: The results indicate that most HCC cells express hTERT RNA and that the promoter is a good candidate as a target for gene therapy. However, careful consideration must be taken concerning the potential effects on lymphocytes.

AB - Background and Aim: Telomerase is the enzyme that synthesizes telomeric DNA, and the activation of telomerase is closely related to cellular immortality. Telomerase activity has been reported in many human cancer tissues and is regulated by the expression of human telomerase reverse transcriptase (hTERT). The aim of the present study was to identify hTERT-expressing cells in human liver tissues and evaluate the feasibility of the hTERT promoter for gene therapy of hepatocellular carcinoma (HCC). Methods: The authors examined the cellular distribution of hTERT transcripts in surgically resected HCC by in situ hybridization. Results: Among 20 samples, hTERT expression was observed in 15 HCC. Transcripts of hTERT were homogenously distributed in the cytoplasm of HCC cells in nine of 15 cases; six of 15 cases displayed a heterogeneous staining pattern. All poorly differentiated HCC that expressed hTERT showed a homogenous pattern of staining. None of the non-cancerous hepatocytes were positive for the transcripts, but infiltrating lymphocytes were faintly stained. The homogenous expression of hTERT was also observed in the vascular invasion of HCC. Conclusions: The results indicate that most HCC cells express hTERT RNA and that the promoter is a good candidate as a target for gene therapy. However, careful consideration must be taken concerning the potential effects on lymphocytes.

KW - Gene therapy

KW - In situ hybridization

KW - Liver

UR - http://www.scopus.com/inward/record.url?scp=10744232968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744232968&partnerID=8YFLogxK

U2 - 10.1046/j.1440-1746.2003.03137.x

DO - 10.1046/j.1440-1746.2003.03137.x

M3 - Article

VL - 18

SP - 1168

EP - 1174

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 10

ER -